in France, Canada and the United States, within 2 weeks of the earthquake, peritraumatic distress was found to be a predictor of disruptive nocturnal behavior and PTSD symptoms among respondents, and that it significantly mediated a relationship between internet coverage of the disaster and presence of PTSD symptoms.
Failure to regulate fear responses to traumatic events could be due to dysfunction in the ACC. 9 As Sekiguchi et al. 1 showed decreased volume of the ACC might reflect genetic and epigenetic vulnerability, and vulnerable individuals might be prone to peritraumatic distress. We suggested that the different types of peritraumatic distress occurring in response to various traumatic events might be important. 7 For example, loss of emotional control and feeling shame might be more important for predicting PTSD than other types of peritraumatic distress in rescue workers after disasters, although helplessness and experiencing physical reactions might be more important in traffic accident survivors. These differences could provide insights into not only effective prevention but also future neurobiological study of PTSD.
The current diagnostic criterion A2 for PTSD requires fear, helplessness or horror at the time of the event. Removal of this criterion from the fifth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-5) has been proposed. 10 This change could be a reasonable one because the positive predictive value of this criterion for PTSD is relatively low, and as many patients with PTSD visit psychiatrists long after a traumatic event, recall bias would be considerable. However, assessment of peritraumatic distress, at least in settings where it could be assessed soon after a traumatic event, could screen out individuals unlikely to develop PTSD as well as contribute to elucidating the pathogenesis of PTSD.
A foremost function of the OFC is its involvement in the extinction of conditioned fear.
1 TV and Internet viewing for extended periods after a traumatic event might be harmful to the OFC structure and consequently impair its important functioning for the extinction of fear memory. Thus the results of Sekiguchi et al.'s 1 neuroimaging study coincide with the findings from epidemiological studies, although it remains unclear whether such viewing might constitute traumatic exposure or be a part of ineffective coping.
The use of longitudinal neuroimaging data to examine vulnerability factors and acquired sign of PTSD symptoms is of considerable interest for both understanding the pathogenesis of PTSD and developing preventive strategies for it. It is our mission to learn more from this latest tragic event for the future. 1 Gene--environment interactions might not only predict onset of disease, but genetic biomarkers might also help the clinician to select the optimal treatment for patients. 2 However, there is a lack of studies on therapygenetics for psychological treatment of psychiatric diseases.
CONFLICT OF INTEREST
The serotonin transporter gene promoter region (5HTTLPR) in depression and anxiety is particularly of interest, because it is associated with response to stress, 3 and may represent susceptibility to environmental influences. 4, 5 Recently, in this journal, Eley et al. 6 reported preliminary results showing that children with an anxiety disorder carrying the short--short (SS) genotype were significantly more likely to respond to cognitive behavioral therapy (CBT) than those carrying a long allele (SL/LL). The authors state that independent replication is necessary. Moreover, a control group not receiving CBT was lacking and the association did only emerge at follow-up. In an independent sample, using a randomized clinical trial design, we examined whether the short--short allele in recurrently depressed patients was associated with better response to CBT in preventing recurrence compared with a control group.
We randomized 187 remitted recurrently depressed adult patients in the Netherlands to either a brief CBT module designed to prevent recurrence, or treatment as usual. 7, 8 Primary outcome was time to recurrence, as assessed prospectively over 5.5 years using the Structured Clinical Interview for DSM-IV. This intervention was effective in preventing recurrence over 5.5 years. 8 We used Cox proportional hazard regression analysis to examine whether patients with the short--short allele responded better to CBT (time to recurrence). From 137 patients, we extracted genomic DNA from blood using established procedures. Patients provided informed consent. In order to perform intention-to-treat analyses, we imputed missing data (26.7%) using multiple imputation. We focused on 180 Caucasians (nonCaucasians N ¼ 7). The 5HTTLPR genotypes were in Hardy--Weinberg equilibrium.
As reported before, 7, 8 Cox regression intention-to-treat analyses revealed that CBT had a preventive effect on time to recurrence, that increased with increasing number of previous episodes (interaction between previous episodes and treatment condition for Caucasian sample: Wald statistic (1, N ¼ 180) ¼ 7.855, Po0.05, hazard ratio ¼ 0.567, 95% confidence interval (CI) ¼ 0.381--0.843. For the total sample: Wald statistic(1, N ¼ 187) ¼ 9.150, Po0.05, hazard ratio adj ¼ 0.547, 95% CI ¼ 0.370--0.809).
The genotyping success rate was 99.3%. Genotype distribution for the Caucasian subset (whole sample) was as follows; LL: 29.1% (28.3%); LS: 52.8% (53.5%); SS: 17.9% (17.7%). Over 5.5 years of follow-up, 76.7% (138/180) experienced a recurrence (75.2% in SS, 77.3% in SL/LL). In the total sample, recurrence rates were 76.1% in SS and 77.6% in SL/LL. As shown in Figure 1 , the 5HTTLPR was not significantly associated with treatment response (no significant treatment condition Â 5HTTLPR Â number of previous episodes interaction effect on time to recurrence; interaction term for Caucasian sample: Wald statistic (1, N ¼ 180) ¼ 0.717, P ¼ 0.418, hazard ratio ¼ 0.271, 95% CI ¼ 0.009--8.560).
We found comparable results controlling for age and gender We could not corroborate the preliminary findings 6 that 5HTTLPR is associated with response to CBT. Apart from 5HTTLPR, several other polymorphisms (and potentially their interactions) might be associated with treatment response. 2 This finding could also indicate that 5HTTLPR does predict CBT response in one population (children with anxiety disorders), but not in the other (recurrently depressed adults). Unfortunately, our sample size is relatively small, therefore additional studies are needed. Clinical trials are necessary to explore whether genetic profiles indeed can be useful biomarkers of psychological treatment outcomes to enhance better patient--treatment matching in psychiatric illnesses.
Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp) Association of DISC1 variants with age of onset in a population-based sample of recurrent major depression The majority of studies investigating the association of DISC1 and mental illness have focussed on clinically ascertained samples (reviewed in Bradshaw et al. 
